Ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate
C24H30N4O5S — CID 3211277
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate
Ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate (PubChem CID 3211277) has the molecular formula C24H30N4O5S and a molecular weight of 486.59 g/mol. Its IUPAC name is ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate.
Molecular Properties
| Compound Name | Ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate |
|---|---|
| PubChem CID | 3211277 |
| Molecular Formula | C24H30N4O5S |
| Molecular Weight | 486.59 g/mol |
| Exact Mass | 486.19 |
| IUPAC Name | ethyl 2-[[2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-[2-(thiophene-2-carbonylamino)acetyl]amino]acetate |
| SMILES | CCOC(=O)CN(C(=O)CNC(=O)c1cccs1)C(C(=O)NC1CCCCC1)c1cccnc1 |
| InChI | InChI=1S/C24H30N4O5S/c1-2-33-21(30)16-28(20(29)15-26-23(31)19-11-7-13-34-19)22(17-8-6-12-25-14-17)24(32)27-18-9-4-3-5-10-18/h6-8,11-14,18,22H,2-5,9-10,15-16H2,1H3,(H,26,31)(H,27,32) |
| InChIKey | KLJVBWUJTDNDMS-UHFFFAOYSA-N |
| XLogP | 2.45 |
| TPSA | 117.70 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.59 |
| LogP ≤ 5 | 2.45 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 3211277 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.